# AVLAYAH

NDC: 84976-001
Generic name: tividenofusp alfa-eknm
Labeler / Manufacturer: Denali Therapeutics Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20260406

FDA application: BLA761485

## Active ingredients

- TIVIDENOFUSP ALFA: 150 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"84976-001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84976-001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=014d92c1-b643-4680-8ca6-f0b3307da915